If the worst happened and your child was diagnosed with cancer you would probably want aggressive therapy for the child with hope for a cure, let alone to save your child’s life. In diseases like childhood leukemia these days, the vast majority of the time, aggressive therapy works.
But when it comes to chronic conditions many parents worry if strong medicines are too strong, or too new, and that there could be unforeseen long-term side effects that made the therapy not worth it.
This very discussion came up as I walked with a friend along Seattle’s Puget Sound. The friend’s daughter has Crohn’s disease, a serious, progressive, auto-immune condition that causes inflammation in the digestive tract, can be disabling, and raise the risk of colon cancer.
In recent years powerful biologic medicines have been approved to treat Crohn’s, even in children. My friend’s daughter began IV infusions every eight weeks. They were told the medicine would be a wonder drug, and for several years it has been. The child has resumed a full life and that has been a tremendous gift. But there continue to be reports of a higher risk of lymphoma, a serious cancer, down the road. It is not a trivial risk. And parents wonder whether there could be other risks that are not yet known. After all, the biologic therapy does powerful work on the immune system, albeit in a very targeted way.
The same balancing act of therapy versus future risk weighs on the minds of parents of children who take anti-depressants, anti-anxiety medicines, and stimulants for ADHD. Are these pills helping the child enjoy a fuller life, and even if they are, could other problems lie ahead?
I, for one, feel a child with poorly treated illness may well be scarred for life. If there is an approved medicine to largely return them to health, I believe it is usually worth the typically small risk of other health concerns years later. Obviously, one must weigh this on an individual basis and it is no easy decision.
I heard how my friend still agonizes about the IV therapy his child continues to receive.